Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

WLLW

Willow Biosciences (WLLW)

Willow Biosciences Inc
Date:
Sort by:
 Showing the most relevant articles for your search:TSX:WLLW
DateTimeSourceHeadlineSymbolCompany
01/20/20257:00AMPR Newswire (US)WILLOW ANNOUNCES INITIATION OF STRATEGIC REVIEW PROCESSTSX:WLLWWillow Biosciences Inc
01/20/20257:00AMPR Newswire (Canada)WILLOW ANNOUNCES INITIATION OF STRATEGIC REVIEW PROCESSTSX:WLLWWillow Biosciences Inc
01/02/20255:49PMPR Newswire (Canada)WILLOW ANNOUNCES CANCELLATION OF PREVIOUSLY ANNOUNCED NON-BROKERED OFFERING TO PURSUE LESS DILUTIVE ALTERNATIVESTSX:WLLWWillow Biosciences Inc
11/12/20247:00AMPR Newswire (US)WILLOW BIOSCIENCES REPORTS THIRD QUARTER 2024 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATETSX:WLLWWillow Biosciences Inc
11/12/20247:00AMPR Newswire (Canada)WILLOW BIOSCIENCES REPORTS THIRD QUARTER 2024 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATETSX:WLLWWillow Biosciences Inc
11/07/20247:00AMPR Newswire (Canada)WILLOW BIOSCIENCES ANNOUNCES NEW PARTNERSHIP WITH A GLOBAL INGREDIENT MANUFACTURER TO ADVANCE DEVELOPMENT OF A HIGH VALUE INGREDIENT FROM ITS PORTFOLIOTSX:WLLWWillow Biosciences Inc
11/07/20247:00AMPR Newswire (US)WILLOW BIOSCIENCES ANNOUNCES NEW PARTNERSHIP WITH A GLOBAL INGREDIENT MANUFACTURER TO ADVANCE DEVELOPMENT OF A HIGH VALUE INGREDIENT FROM ITS PORTFOLIOTSX:WLLWWillow Biosciences Inc
09/18/20247:00PMPR Newswire (Canada)WILLOW ANNOUNCES A SECOND PROGRAM WITH GLOBAL INGREDIENT MANUFACTURER TO DEVELOP AN ENZYME FOR MANUFACTURING A LARGE VOLUME ACTIVE PHARMACEUTICAL INGREDIENTTSX:WLLWWillow Biosciences Inc
09/18/20247:00PMPR Newswire (US)WILLOW ANNOUNCES A SECOND PROGRAM WITH GLOBAL INGREDIENT MANUFACTURER TO DEVELOP AN ENZYME FOR MANUFACTURING A LARGE VOLUME ACTIVE PHARMACEUTICAL INGREDIENTTSX:WLLWWillow Biosciences Inc
09/05/20241:00PMAllPennyStocks.comBiotech on An Upswing Following Licensing and Royalty AgreementTSX:WLLWWillow Biosciences Inc
09/05/20247:00AMPR Newswire (US)WILLOW ANNOUNCES COMMERCIAL LICENSE AND ROYALTY AGREEMENT WITH KALSEC INC.TSX:WLLWWillow Biosciences Inc
09/05/20247:00AMPR Newswire (Canada)WILLOW ANNOUNCES COMMERCIAL LICENSE AND ROYALTY AGREEMENT WITH KALSEC INC.TSX:WLLWWillow Biosciences Inc
08/12/20247:00AMPR Newswire (US)WILLOW BIOSCIENCES REPORTS SECOND QUARTER 2024 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATETSX:WLLWWillow Biosciences Inc
08/12/20247:00AMPR Newswire (Canada)WILLOW BIOSCIENCES REPORTS SECOND QUARTER 2024 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATETSX:WLLWWillow Biosciences Inc
08/07/20247:00AMPR Newswire (US)WILLOW BIOSCIENCES ANNOUNCES NEW FUNDED BIOPESTICIDES RESEARCH AND DEVELOPMENT PARTNERSHIP AFTER SUCCESSFULLY COMPLETING FEASIBILITY STUDYTSX:WLLWWillow Biosciences Inc
08/07/20247:00AMPR Newswire (Canada)WILLOW BIOSCIENCES ANNOUNCES NEW FUNDED BIOPESTICIDES RESEARCH AND DEVELOPMENT PARTNERSHIP AFTER SUCCESSFULLY COMPLETING FEASIBILITY STUDYTSX:WLLWWillow Biosciences Inc
07/26/20245:48PMPR Newswire (Canada)WILLOW BIOSCIENCES ANNOUNCES ANNUAL GENERAL AND SPECIAL MEETING VOTING RESULTSTSX:WLLWWillow Biosciences Inc
07/18/20248:49AMPR Newswire (Canada)WILLOW BIOSCIENCES ANNOUNCES CLOSING OF PRIVATE PLACEMENT OF UNITSTSX:WLLWWillow Biosciences Inc
06/26/20244:30PMPR Newswire (Canada)WILLOW BIOSCIENCES PROVIDES CORPORATE UPDATE AND ANNOUNCES SIGNING OF A NEW PARTNERED PROGRAMTSX:WLLWWillow Biosciences Inc
06/26/20244:30PMPR Newswire (US)WILLOW BIOSCIENCES PROVIDES CORPORATE UPDATE AND ANNOUNCES SIGNING OF A NEW PARTNERED PROGRAMTSX:WLLWWillow Biosciences Inc
06/03/20247:00AMPR Newswire (Canada)WILLOW ANNOUNCES BROKERED PRIVATE PLACEMENT OFFERING TO RAISE UP TO $3.0 MILLIONTSX:WLLWWillow Biosciences Inc
05/30/20247:00AMPR Newswire (US)WILLOW ANNOUNCES MULTI-PRODUCT DEVELOPMENT AND LICENSING PARTNERSHIP WITH LAURUS LABS FOR MANUFACTURING ACTIVE PHARMACEUTICAL INGREDIENTSTSX:WLLWWillow Biosciences Inc
05/30/20247:00AMPR Newswire (Canada)WILLOW ANNOUNCES MULTI-PRODUCT DEVELOPMENT AND LICENSING PARTNERSHIP WITH LAURUS LABS FOR MANUFACTURING ACTIVE PHARMACEUTICAL INGREDIENTSTSX:WLLWWillow Biosciences Inc
05/13/20247:00AMPR Newswire (US)WILLOW BIOSCIENCES REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATETSX:WLLWWillow Biosciences Inc
05/13/20247:00AMPR Newswire (Canada)WILLOW BIOSCIENCES REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATETSX:WLLWWillow Biosciences Inc
03/28/20247:30PMPR Newswire (Canada)WILLOW BIOSCIENCES REPORTS FOURTH QUARTER AND FISCAL YEAR 2023 FINANCIALS AND OPERATIONS AND FILING OF ITS 2023 AIFTSX:WLLWWillow Biosciences Inc
03/28/20247:30PMPR Newswire (US)WILLOW BIOSCIENCES REPORTS FOURTH QUARTER AND FISCAL YEAR 2023 FINANCIALS AND OPERATIONS AND FILING OF ITS 2023 AIFTSX:WLLWWillow Biosciences Inc
02/29/20246:00PMPR Newswire (US)WILLOW BIOSCIENCES ANNOUNCES SECOND STRATEGIC INVESTMENT FROM KALSECTSX:WLLWWillow Biosciences Inc
02/29/20246:00PMPR Newswire (Canada)WILLOW BIOSCIENCES ANNOUNCES SECOND STRATEGIC INVESTMENT FROM KALSECTSX:WLLWWillow Biosciences Inc
02/20/20246:00PMPR Newswire (US)WILLOW BIOSCIENCES ANNOUNCES STRATEGIC INVESTMENT FROM KALSEC TO DEVELOP INNOVATIVE NATURAL FOOD INGREDIENTSTSX:WLLWWillow Biosciences Inc
 Showing the most relevant articles for your search:TSX:WLLW